GLEAM

Sodium-GLucosE co-trAnsporter 2 inhibitors to reduce the risk of deMentia in patients with Atrial fibrillation: GLEAM randomized control trial. 

If you experience any issues with the electronic health record searches, please contact nw.rrdn@nihr.ac.uk